Skip to main content
OpenTrials
Completed

NCT Number: NCT02146638

Post Operative Pain Control: Morphine vs Fentanyl

Aim of this study is to compare benefits and disadvantages in using continuous infusion of morphine or fentanyl for post operative analgesia.

Completed

Looking for future studies?

Notify Me

Key information

Age range

35 year–59 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

catholic University of the sacred Heart

Rome, 00168, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ASA 1 or 2 patients
  • undergoing major gynaecological surgery

Exclusion criteria

  • age > 60 years
  • obesity (BMI>30 Kg/m2)
  • cardiac and respiratory diseases
  • renal impairment
  • liver disorders
  • allergies to any drug used in the study

Treatment and study plan

Morphine

Drug

Fentanyl

Drug

Other names: Fentanest

Primary outcomes

  1. pain scores

    Time frame: data were recorded during the 24 post operative hours

    data were recorded at 1,6,18 and 24 hours after surgery

Secondary outcomes

  1. analgesic requirements

    Time frame: during the 24 hours after surgery

    if VAS value was equal or higher than 6 patients received ketorolac 30 mg iv

Sponsors and collaborators

Lead sponsor

Catholic University of the Sacred Heart

Other

Registry information

Official study title

Post Operative Pain Control: Continuous Infusion of Morphine vs Fentanyl. Clinical Outcomes

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
May 26, 2014
Registry last updated
May 26, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.